Skip to main content
. Author manuscript; available in PMC: 2015 Sep 18.
Published in final edited form as: J Neurooncol. 2009 Jun 12;95(2):199–209. doi: 10.1007/s11060-009-9926-0

Fig. 1.

Fig. 1

Sensitivity of CD133− (panel A) and CD133+ (panel B) glioma cells from freshly disaggregated xenografts to wild-type HSV-1(F) infection as measured by the alamarBlue assay at a given multiplicity of infection (MOI) compared to a control with a 3 day incubation period